How will I be monitored for recurrence after treatment (e.g., CEA blood tests, colonoscopies, scans)? What lifestyle...

Colorectal Cancer Survivorship: Monitoring and Lifestyle After Treatment

I'm glad you're thinking ahead about your post-treatment care plan. Let me break down what the evidence shows about surveillance and lifestyle factors for CRC survivors.

---

1) Monitoring for Recurrence After Treatment

Your surveillance plan depends on your stage of disease and whether you had surgery. Here's what the NCCN Guidelines recommend:

For Stage I Disease (Lower Risk)

According to the NCCN Colon Cancer Guidelines, if you had stage I disease, you'll need less intensive monitoring because your recurrence risk is lower:

• Colonoscopy: At 1 year after surgery, then at 3 years, then every 5 years thereafter
• CEA blood tests: Not routinely recommended for stage I
• CT scans: Not routinely recommended
• Physical exams: As part of regular follow-up care

For Stage II or III Disease (Higher Risk)

This is where surveillance becomes more comprehensive. The NCCN Guidelines recommend:

Blood Tests:

• CEA (carcinoembryonic antigen) every 3-6 months for the first 2 years, then every 6 months for a total of 5 years
  • CEA is a tumor marker—a protein that can be elevated when cancer is present. It helps detect recurrence early, though it's not perfect (some people have false positives or false negatives)

Imaging (CT Scans):

• Chest, abdomen, and pelvis CT scans every 6-12 months for up to 5 years
  • These scans look for signs of cancer returning in the lungs, liver, or other organs
  • The NCCN notes that more frequent scanning (category 2B recommendation) may be considered, but annual scans are standard
  • Important: Routine CEA monitoring and CT scanning are not recommended beyond 5 years

Colonoscopy:

• At approximately 1 year after surgery (or 3-6 months if you couldn't have a complete colonoscopy before surgery)
• Then at 3 years, then every 5 years thereafter
• If advanced adenomas (precancerous polyps) are found, repeat in 1 year

Physical Exams:

• Every 3-6 months for the first 2 years, then every 6 months for a total of 5 years

Important Note About PET/CT Scans

The NCCN Guidelines specifically state that PET/CT scans are NOT recommended for routine surveillance of CRC recurrence. While they can be useful in specific situations (like when CEA is rising but other imaging is normal), they're not part of standard follow-up.

What If Your CEA Rises?

If your CEA level increases over time, your doctor will order additional workup including:

• Colonoscopy
• Chest, abdomen, and pelvis CT scans
• Physical examination
• Possibly PET/CT scan if imaging is otherwise normal

This helps identify recurrence early when it may still be treatable.

---

2) Lifestyle Factors for Survivorship

The evidence on lifestyle is quite strong. According to the NCCN Guidelines, what you do after treatment significantly impacts your outcomes. Here's what matters:

Physical Activity

This is one of the most important factors. The research shows:

• Patients who engaged in regular exercise had better disease-free survival (meaning they stayed cancer-free longer)
• A study in the CALGB 89803 trial found that disease-free survival was directly related to the amount of exercise patients did
• More recent data shows that both pre- and post-diagnosis physical activity decreases CRC-specific mortality
• In one study, women with high levels of physical activity had significantly lower cancer-specific mortality and all-cause mortality

NCCN Recommendation: Aim for at least 30 minutes of moderate-intensity activity on most days of the week

Note: If you have treatment side effects like neuropathy (nerve damage) or an ostomy (surgically created opening), your activity plan may need modification—discuss this with your care team.

Diet and Nutrition

The evidence shows that what you eat matters for recurrence risk:

Foods Associated with Better Outcomes:

• More fruits and vegetables
• Poultry and fish (especially fish—post-diagnosis fish consumption is associated with better prognosis)
• Whole grains
• Higher calcium intake (some evidence suggests this may lower death risk)
• Legumes (beans, lentils)

Foods Associated with Worse Outcomes:

• Red and processed meats (survivors with consistently high intake had higher CRC-specific mortality)
• Refined grains and concentrated sweets
• Sugar-sweetened beverages (high intake was associated with increased recurrence and death risk in stage III patients)

NCCN Recommendation: Eat a diet with emphasis on plant sources, including fruits, vegetables, whole grains, and legumes; limit red meat; and avoid sugar-sweetened beverages.

Body Weight

• Pre-diagnosis obesity (before your cancer diagnosis) was associated with increased recurrence and death risk
• Patients with BMI ≥35 kg/m² had higher recurrence risk
• The NCCN recommends achieving and maintaining a healthy body weight

Note: In the metastatic (advanced) setting, the relationship is more complex, but for early-stage disease, maintaining a healthy weight is protective.

Smoking and Alcohol

• Smoking is associated with poor prognosis—if you smoke, quitting is important
• Limit or eliminate alcohol consumption

Dietary Glycemic Load

• Higher dietary glycemic load (foods that cause rapid blood sugar spikes) was associated with increased recurrence and mortality in stage III patients
• This suggests choosing lower-glycemic foods may be beneficial

Vitamin D

The evidence here is mixed and inconclusive. While some studies show associations between higher vitamin D levels and better survival, the NCCN Guidelines note:

• A randomized trial showed that vitamin D supplementation did not prevent adenoma recurrence
• The effect may depend on your vitamin D receptor genetics
• The NCCN does NOT currently recommend routine vitamin D screening or supplementation for CRC patients

However, maintaining adequate vitamin D through sun exposure and diet is still reasonable as part of overall health.

Aspirin for Secondary Prevention

Interestingly, the NCCN Guidelines mention that low-dose aspirin (325 mg daily) may reduce recurrence and death risk in CRC survivors. However:

• Aspirin increases the risk of GI bleeding and hemorrhagic stroke
• These risks should be discussed with your doctor before starting

---

Summary: What the Evidence Shows

Strong Evidence (Cite NCCN Guidelines): ✅ Surveillance schedule based on stage (CEA, CT scans, colonoscopy)
✅ Physical activity reduces recurrence and mortality
✅ Diet rich in plants, fish, and whole grains improves outcomes
✅ Avoiding red/processed meats and sugar-sweetened beverages
✅ Maintaining healthy body weight
✅ Smoking cessation and limiting alcohol

Limited/Mixed Evidence: ⚠️ Vitamin D supplementation (not routinely recommended)
⚠️ Aspirin use (potential benefit but bleeding risks)

---

Questions to Ask Your Oncology Team

1. Based on my stage and pathology, what is MY specific surveillance schedule? (Confirm the frequency of CEA tests, CT scans, and colonoscopies)

2. Should I consider low-dose aspirin, and what are the risks for me specifically?

3. Do I have any treatment side effects that would require modifying my exercise plan? (e.g., ostomy, neuropathy, lymphedema)

4. Would a referral to a nutritionist or dietitian be helpful to create a personalized eating plan?

5. Are there any clinical trials for CRC survivors focused on lifestyle interventions or novel monitoring approaches?

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.